Since two groundbreaking treatments were approved in late 2023, only a handful of patients have been able to access the ...

People with sickle cell disease often struggle with memory, focus, learning and problem solving, setting them back in school ...

Rigel has enrolled the first subject in a Phase I trial of its oral spleen tyrosine kinase (SYK) inhibitor, fostamatinib, to ...

WINSTON-SALEM, N.C. — Emory Moore, a 12-year-old treated at Brenner Children’s Hospital for sickle cell disease, received a special day with the Wake Forest basketball team. Despite her diagnosis, ...

IMMvention retained rights to use its technology to potentially pursue other targets, such as Parkinson’s or Alzheimer’s ...

Individuals with sickle cell disease—a chronic illness where misshapen, sticky blood cells clump together, reducing oxygen ...

Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the ...

Jalen Ribot, an 18-year-old St. Christopher's Hospital patient who has battled sickle cell anemia since he was a child, was ...

Statistics from the district health department indicate that in 2023, suspected cases of sickle cells stood at 1,456 and in ...

A groundbreaking study reveals that individuals with sickle cell disease show premature brain aging, appearing 14 years older ...

The CDC states that, on average, sickle cell disease reduces a patient's lifespan by more than 20 years, which is why Carla ...

IMMvention and Novo Nordisk form a partnership to co-develop oral therapies for sickle cell disease, focusing on BACH1 ...